Balancing Safety and Efficacy of Epidermal Growth Factor Receptor Inhibitors in Patients With Squamous Cell Carcinoma of the Head and Neck. [electronic resource]
Producer: 20160921Description: 1393-403 p. digitalISSN:- 1549-490X
- Antineoplastic Agents -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Squamous Cell -- drug therapy
- Cetuximab -- administration & dosage
- Chemotherapy, Adjuvant
- ErbB Receptors -- antagonists & inhibitors
- Head and Neck Neoplasms -- drug therapy
- Humans
- Molecular Targeted Therapy -- methods
- Protein Kinase Inhibitors -- adverse effects
- Squamous Cell Carcinoma of Head and Neck
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.